Comparison of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the primary prevention of myocardial infarction in hypertensive patients
- 15 August 2004
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 94 (4) , 479-481
- https://doi.org/10.1016/j.amjcard.2004.04.063
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirinJournal of the American College of Cardiology, 2004
- Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study)The Lancet, 2003
- Renin-Angiotensin System and Atherothrombotic DiseaseArchives of internal medicine (1960), 2003
- Risk of acute first myocardial infarction and use of nicotine patches in a general populationJournal of the American College of Cardiology, 2001
- The multiple actions of angiotensin II in atherosclerosisRegulatory Peptides, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast CancerNew England Journal of Medicine, 1993
- Comparison of Uninsured and Privately Insured Hospital PatientsPublished by American Medical Association (AMA) ,1991
- THE IMPACT OF CONFOUNDER SELECTION CRITERIA ON EFFECT ESTIMATIONAmerican Journal of Epidemiology, 1989
- A short questionnaire for the measurement of habitual physical activity in epidemiological studiesThe American Journal of Clinical Nutrition, 1982